These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Effect of efflux pump inhibitors on drug susceptibility of ofloxacin resistant Mycobacterium tuberculosis isolates. Singh M; Jadaun GP; Ramdas ; Srivastava K; Chauhan V; Mishra R; Gupta K; Nair S; Chauhan DS; Sharma VD; Venkatesan K; Katoch VM Indian J Med Res; 2011 May; 133(5):535-40. PubMed ID: 21623040 [TBL] [Abstract][Full Text] [Related]
3. [Investigation of Efflux Pump Genes in Resistant Mycobacterium tuberculosis Complex Clinical Isolates Exposed to First Line Antituberculosis Drugs and Verapamil Combination]. Özgür D; Ersoy L; Ülger M; Tezcan Ülger S; Aslan G Mikrobiyol Bul; 2023 Apr; 57(2):207-219. PubMed ID: 37067206 [TBL] [Abstract][Full Text] [Related]
4. Efflux pump effects on levofloxacin resistance in Teng T; Chen S; Huo F; Jia J; Zhao L; Jiang G; Wang F; Chu N; Huang H Antimicrob Agents Chemother; 2024 May; 68(5):e0134823. PubMed ID: 38572960 [No Abstract] [Full Text] [Related]
5. Ofloxacin resistance in Mycobacterium tuberculosis is associated with efflux pump activity independent of resistance pattern and genotype. Sun Z; Xu Y; Sun Y; Liu Y; Zhang X; Huang H; Li C Microb Drug Resist; 2014 Dec; 20(6):525-32. PubMed ID: 24940805 [TBL] [Abstract][Full Text] [Related]
6. High incidence of fluoroquinolone resistance and effect of efflux pump inhibitors on moxifloxacin resistance among Mycobacterium tuberculosis isolates causing urinary tract infection in Taiwan. Chien JY; Yu CJ; Hsueh PR Int J Antimicrob Agents; 2017 Sep; 50(3):491-495. PubMed ID: 28668684 [TBL] [Abstract][Full Text] [Related]
7. Rifampicin reduces susceptibility to ofloxacin in rifampicin-resistant Mycobacterium tuberculosis through efflux. Louw GE; Warren RM; Gey van Pittius NC; Leon R; Jimenez A; Hernandez-Pando R; McEvoy CR; Grobbelaar M; Murray M; van Helden PD; Victor TC Am J Respir Crit Care Med; 2011 Jul; 184(2):269-76. PubMed ID: 21512166 [TBL] [Abstract][Full Text] [Related]
8. Antimycobacterial activity of five efflux pump inhibitors against Mycobacterium tuberculosis clinical isolates. Li G; Zhang J; Li C; Guo Q; Jiang Y; Wei J; Qiu Y; Zhao X; Zhao LL; Lu J; Wan K J Antibiot (Tokyo); 2016 Mar; 69(3):173-5. PubMed ID: 26464012 [No Abstract] [Full Text] [Related]
9. [Effects of four efflux pump inhibitors on the activities of clarithromycin against Teng TL; Shang YY; Huang HR; Chu NH; Chen ST Zhonghua Jie He He Hu Xi Za Zhi; 2022 May; 45(5):468-474. PubMed ID: 35527462 [No Abstract] [Full Text] [Related]
10. Farnesol, a potential efflux pump inhibitor in Mycobacterium smegmatis. Jin J; Zhang JY; Guo N; Sheng H; Li L; Liang JC; Wang XL; Li Y; Liu MY; Wu XP; Yu L Molecules; 2010 Oct; 15(11):7750-62. PubMed ID: 21042264 [TBL] [Abstract][Full Text] [Related]
11. Microarray analysis of efflux pump genes in multidrug-resistant Mycobacterium tuberculosis during stress induced by common anti-tuberculous drugs. Gupta AK; Katoch VM; Chauhan DS; Sharma R; Singh M; Venkatesan K; Sharma VD Microb Drug Resist; 2010 Mar; 16(1):21-8. PubMed ID: 20001742 [TBL] [Abstract][Full Text] [Related]
12. Study of efflux pump gene expression in rifampicin-monoresistant Mycobacterium tuberculosis clinical isolates. Li G; Zhang J; Guo Q; Wei J; Jiang Y; Zhao X; Zhao LL; Liu Z; Lu J; Wan K J Antibiot (Tokyo); 2015 Jul; 68(7):431-5. PubMed ID: 25690361 [TBL] [Abstract][Full Text] [Related]
13. Expression analysis of 10 efflux pump genes in multidrug-resistant and extensively drug-resistant Mycobacterium tuberculosis clinical isolates. Kardan-Yamchi J; Kazemian H; Haeili M; Harati AA; Amini S; Feizabadi MM J Glob Antimicrob Resist; 2019 Jun; 17():201-208. PubMed ID: 30654147 [TBL] [Abstract][Full Text] [Related]
14. Characterization of tetracycline resistance mediated by the efflux pump Tap from Mycobacterium fortuitum. Ramón-García S; Martín C; Aínsa JA; De Rossi E J Antimicrob Chemother; 2006 Feb; 57(2):252-9. PubMed ID: 16373429 [TBL] [Abstract][Full Text] [Related]
15. Targeting bedaquiline mycobacterial efflux pump to potentially enhance therapy in Martin A; Bouyakoub Y; Soumillion K; Mantu EON; Colmant A; Rodriguez-Villalobos H Int J Mycobacteriol; 2020; 9(1):71-75. PubMed ID: 32474492 [TBL] [Abstract][Full Text] [Related]
16. jefA (Rv2459), a drug efflux gene in Mycobacterium tuberculosis confers resistance to isoniazid & ethambutol. Gupta AK; Reddy VP; Lavania M; Chauhan DS; Venkatesan K; Sharma VD; Tyagi AK; Katoch VM Indian J Med Res; 2010 Aug; 132():176-88. PubMed ID: 20716818 [TBL] [Abstract][Full Text] [Related]
17. Investigation of efflux pump genes in isoniazid resistant Mycobacterium tuberculosis isolates. Kaya H; Ersoy L; Ülger M; Bozok T; Aslan G Indian J Med Microbiol; 2023; 46():100428. PubMed ID: 37945121 [TBL] [Abstract][Full Text] [Related]
18. The human proton pump inhibitors inhibit Lake MA; Adams KN; Nie F; Fowler E; Verma AK; Dei S; Teodori E; Sherman DR; Edelstein PH; Spring DR; Troll M; Ramakrishnan L Proc Natl Acad Sci U S A; 2023 Feb; 120(7):e2215512120. PubMed ID: 36763530 [TBL] [Abstract][Full Text] [Related]
19. Carbonyl Cyanide 3-Chloro Phenyl Hydrazone (CCCP) Restores the Colistin Sensitivity in Zoaiter M; Zeaiter Z; Mediannikov O; Sokhna C; Fournier PE Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768429 [No Abstract] [Full Text] [Related]
20. Effect of efflux pump inhibitors on the susceptibility of Jaiswal I; Jain A; Verma SK; Singh P; Kant S; Singh M Lung India; 2017; 34(6):499-505. PubMed ID: 29098993 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]